Vertaling van "compared with clopidogrel alone after " (Nederlands → Frans) :

Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial.
Sacco RL, Diener HC, Yusuf S et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008; 359:1238-51.

LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-riskpatients (MATCH): randomized, double-blind, placebo-controlled trial.
LM etal. Aspirin and clopidogrel compared with clopidogrel alone afterrecent ischaemic stroke or transient ischaemic attack in high-riskpatients (MATCH): randomized, double-blind, placebo-controlled trial.

A study in premenopausal women with hormone-sensitive, early-stage breast cancer showed the addition of Zometa to hormone therapy after surgery significantly reduced the risk of recurrence or death beyond benefits achieved with hormone therapy alone.
Une étude, portant sur des femmes préménopausées atteintes d’un cancer du sein au stade précoce, a montré que l’adjonction de Zometa à un traitement hormonal après intervention chirurgicale permettait une réduction significative du risque de récidive ou de décès, au-delà des bénéfices obtenus par la seule thérapie hormonale.

Results from the Phase III RADIANT-2 study showed Afinitor plus Sandostatin LAR extended time without tumor growth from 11.3 to 16.4 months when compared to Sandostatin LAR alone in patients with advance neuroendocrine tumors (hazard ratio=0.77 [95% confidence interval, 0.59 to 1.00]; p=0.026).
prolongeait la période sans croissance de la tumeur de 11,3 à 16,4 mois en moyenne, en comparaison de Sandostatine LAR administré seul chez les malades atteints de tumeurs neuroendocrines avancées («hazard ratio» =0.77 [95% intervalle de confiance, 0.59 à 1.00]; p=0.026).

Gait analysis after initial non-operative treatment for clubfeet: intermediate term follow up at age 5 We conducted gait analysis following initial nonoperative clubfoot treatment to compare lower extremity kinematic (eg, ankle motion) and kinetic (eg, ankle power) characteristics between patients treated as infants with Ponseti casting or French phys [ publicatie ] [ 4/03/2012 ]
Concurrent musculoskeletal dynamics and finite element analysis predicts altered gait patterns to reduce foot tissue loading Current computational methods for simulating locomotion have primarily used muscle-driven multibody dynamics, in which neuromuscular control is optimized. [ publication ] [ 4/03/2012 ]

Suicide as compared with other causes of death Taking into account the entire population, there were 2 146 deaths by suicide in 1997 out of a total of 103 800 deaths. This makes suicide the 10 th most frequent cause of death (after, in decreasing order, diseases of the circulatory system, tumours, diseases of the respiratory system, cerebrovascular diseases, diseases of the gastrointestinal tract, diseases of the nervous system and the sense organs, endocrine and blood diseases, mental disorders, ill-defined symptoms and clinical pictures) (see table 3).
Le suicide par rapport aux autres causes de décès Avec 2146 suicides sur un total de 103.800 décès en 1997, au niveau de l’ensemble de la population, le suicide est la 10 e cause de décès (après et par ordre décroissant, les maladies de l’appareil circulatoire, les tumeurs, les maladies de l’appareil respiratoire, les maladies vasculaires cérébrales, les maladies de l’appareil digestif, les maladies du système nerveux et des organes de sens, les maladies endocriniennes et du sang, les troubles mentaux, les symptômes et états morbides mal définis) (voir tableau 3).